NI
HALO icon

NDVR Inc’s Halozyme HALO Stock Holding History

NDVR Inc’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$240K Buy
+3,561
New +$240K 0.2% 91

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NDVR Inc's HALO Position: Q4 2025 in Review

NDVR Inc opened a new position in Halozyme (HALO) in Q4 2025: 3,561 shares worth $240K. The stake represents 0.2% of the portfolio and ranks #91 among its holdings.

617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • NDVR Inc held 3,561 shares of Halozyme worth $240K as of Q4 2025.
  • Halozyme was a new NDVR Inc position in Q4 2025.
  • Halozyme made up 0.2% of NDVR Inc's portfolio in Q4 2025, its #91 holding.
  • 617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on NDVR Inc's 13F filing for Q4 2025, filed 12 Feb 2026.